| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 31.1× | −1.7× | |
| Price / Book | 2.1× | 2.0× | |
| Price / Sales | 2.4× | 4.0× | |
| Price / Free cash flow | 19.6× | −1.6× | |
| EV / EBITDA | 14.2× | −1.2× | |
| Earnings yield | 3.2% | −14.6% | |
| Free cash flow yield | 5.1% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,248.92 | −0.65% | $1.18T | 57.3× | 77.8% | +16.7% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $254.25 | −0.51% | $612.72B | 23.0× | 32.9% | +33.7% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $284.35 | −0.37% | $502.48B | 119.3× | −129.2% | +26.2% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $403.58 | +0.54% | $362.25B | 29.9× | 12.8% | +11.2% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.65 | −0.89% | $356.88B | 19.7× | 34.7% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.68 | +0.04% | $278.74B | 19.8× | 30.5% | +15.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $165.14 | −0.16% | $256.12B | 25.0× | 21.1% | −2.2% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $678.88 | −1.61% | $251.01B | 37.9× | 12.6% | +30.7% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $428.36 | −0.96% | $231.58B | 30.3× | 89.1% | +45.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $155.19 | −0.64% | $192.43B | 22.8× | 37.5% | +32.0% |
